Literature DB >> 11522622

TSU-Pr1 and JCA-1 cells are derivatives of T24 bladder carcinoma cells and are not of prostatic origin.

A van Bokhoven1, M Varella-Garcia, C Korch, G J Miller.   

Abstract

We have shown previously that the putative prostate carcinoma cell lines TSU-Pr1 and JCA-1 share a common origin. The observation that these cell lines have p53 and Ha-ras mutations identical to those in bladder carcinoma cell line T24 prompted us to investigate their possible interrelations. We used cytogenetics and DNA profiling to compare the genetic backgrounds of the three cell lines. At least 12 structural chromosomal abnormalities are shared between T24, TSU-Pr1, and JCA-1 cells. DNA profiles were identical for all three cell lines. These results clearly indicate that the cell lines TSU-Pr1 and JCA-1 are not of prostatic origin but are derivatives of the bladder carcinoma cell line T24. TSU-Pr1 and, to a lesser extent, JCA-1 are frequently used as models in prostate cancer research, and numerous publications have appeared based on these lines. Several other T24 cross-contaminants have been identified in the past, and some of these, such as ECV304, continue to be used under the wrong identity. Our findings highlight the insidious problem that can occur when information regarding cross-contamination does not reach individual researchers and/or the importance of the problem is not fully acknowledged.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11522622

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  36 in total

1.  MIM, a potential metastasis suppressor gene in bladder cancer.

Authors:  Young-Goo Lee; Jill A Macoska; Susan Korenchuk; Kenneth J Pienta
Journal:  Neoplasia       Date:  2002 Jul-Aug       Impact factor: 5.715

Review 2.  Cell line misidentification: the beginning of the end.

Authors: 
Journal:  Nat Rev Cancer       Date:  2010-05-07       Impact factor: 60.716

3.  LCC15-MB cells are MDA-MB-435: a review of misidentified breast and prostate cell lines.

Authors:  Erik W Thompson; Mark Waltham; Susan J Ramus; Anne-Marie Hutchins; Jane E Armes; Ian G Campbell; Elizabeth D Williams; Phillip R Thompson; James M Rae; Michael D Johnson; Robert Clarke
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

4.  VICKZ proteins mediate cell migration via their RNA binding activity.

Authors:  Froma Oberman; Kinneret Rand; Yael Maizels; Ariel M Rubinstein; Joel K Yisraeli
Journal:  RNA       Date:  2007-07-24       Impact factor: 4.942

5.  False cell lines: The problem and a solution.

Authors:  John R Masters
Journal:  Cytotechnology       Date:  2002-07       Impact factor: 2.058

6.  Combined therapeutic effects of adenoviral vector-mediated GLIPR1 gene therapy and radiotherapy in prostate and bladder cancer models.

Authors:  Tetsuo Fujita; Takefumi Satoh; Terry L Timme; Takahiro Hirayama; Julie X Zhu; Nobuyuki Kusaka; Koji Naruishi; Guang Yang; Alexei Goltsov; Jianxiang Wang; Maria T Vlachaki; Bin S Teh; E Brian Butler; Timothy C Thompson
Journal:  Urol Oncol       Date:  2013-02-20       Impact factor: 3.498

7.  Upregulated MT1-MMP/TIMP-2 axis in the TSU-Pr1-B1/B2 model of metastatic progression in transitional cell carcinoma of the bladder.

Authors:  Christine L Chaffer; Bonnie Dopheide; Daniel R McCulloch; Allan B Lee; Jane M Moseley; Erik W Thompson; Elizabeth D Williams
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

Review 8.  Potential utility and limitations of thyroid cancer cell lines as models for studying thyroid cancer.

Authors:  Tania Pilli; Kanteti V Prasad; Shankar Jayarama; Furio Pacini; Bellur S Prabhakar
Journal:  Thyroid       Date:  2009-12       Impact factor: 6.568

9.  CINP is a novel cofactor of KLF5 required for its role in the promotion of cell proliferation, survival and tumor growth.

Authors:  Qiao Wu; Changying Fu; Menglin Li; Juan Li; Zhigui Li; Leilei Qi; Xinpei Ci; Gui Ma; Ang Gao; Xing Fu; Jun A; Na An; Mingcheng Liu; Yixiang Li; Jamie L King; Liya Fu; Baotong Zhang; Jin-Tang Dong
Journal:  Int J Cancer       Date:  2018-10-26       Impact factor: 7.396

Review 10.  Short tandem repeat profiling: part of an overall strategy for reducing the frequency of cell misidentification.

Authors:  Raymond W Nims; Greg Sykes; Karin Cottrill; Pranvera Ikonomi; Eugene Elmore
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-10-07       Impact factor: 2.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.